Mo-P1:107 Serum LP(A) concentrations in a group of dislipaemic patients attended in corporació parc tauli (original) (raw)

2006, Atherosclerosis Supplements

AI-generated Abstract

This study investigates the impact of pioglitazone on serum LP(A) concentrations among dislipidemic patients. The findings reveal that after 6 weeks of treatment with pioglitazone, there is a significant shift in cholesterol patterns from type B to type A, suggesting its potential role in improving lipid profiles in non-diabetic patients undergoing concurrent statin and niacin therapy. In addition, the research evaluates various factors associated with apoE genotypes and their correlation with metabolic syndrome in the Romanian population, emphasizing the importance of genetic risk factors in cardiovascular diseases.